Implant offers potential long-term HIV protection

 Modeling predicted a 2 mL and 3 mL injection can sustain plasma concentrations of CAB above levels needed for protection against HIV in humans for 4 and 5 months respectively.

© 2024 Thiratti. All rights reserved.